Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

415

HTML

3781

Figures (1-2)

252

Tables (1-4)

227

Sum=4675

Publishing Process of This Article

Item

Count

Browse

1267

Download

1173

Sum=2440

Apr 15, 2013 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Oncol. Apr 15, 2013; 5(4): 81-87
Published online Apr 15, 2013. doi: 10.4251/wjgo.v5.i4.81

Table 4 Significant prognostic factors by multivariate analysis

Variable	HR	95%CI	P value
Serum CEA (< 2.5 ng/mL ≥ 2.5 ng/mL)	1.68	1.05-2.66	0.027
Lymph node metastasis (yes vs no)	2.27	1.24-4.12	0.007
Receiving adjuvant chemotherapy (yes vs no)	0.71	0.49-1.02	0.067
Surgical margin (negative vs positive)	0.72	0.49-1.06	0.094

CEA: Carcinoembryonic antigen; HR: Hazard ratio.

Citation: Wirasorn K, Ngamprasertchai T, Chindaprasirt J, Sookprasert A, Khantikaew N, Pakkhem A, Ungarereevittaya P. Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. World J Gastrointest Oncol 2013; 5(4): 81-87
URL: https://www.wjgnet.com/1948-5204/full/v5/i4/81.htm
DOI: https://dx.doi.org/10.4251/wjgo.v5.i4.81